Rising manufacturer discounts for prescription drugs have resulted in increasingly diverging trends between the price tag of medications (list prices) and the average revenue to pharmaceutical manufacturers per unit after discounts (net prices). Hernandez will present her research tracking the flow of cash across the drug supply chain. Using insulin as a case-study, she will describe time trends in list prices and net prices, and she will quantify to what extent differences are driven by rebates negotiated between manufacturers and pharmacy benefit managers. Finally, she will describe implications of these pricing dynamics for current policy-making.


Hernandez is a professor with tenure at the UC San Diego’s Skaggs School of Pharmacy and Pharmaceutical Sciences. Her research has focused on the study of medications for stroke prevention and the examination of drivers of drug prices and she has authored more than 100 scientific articles. Hernandez currently serves as the National Academy of Medicine Fellow in Pharmacy. Hernandez received her PharmD from the University of Navarra in Spain; and her Ph.D. in health services research and policy from the University of Pittsburgh. Prior to joining UCSD, she served on the faculty at the University of Pittsburgh. She was recognized on the Forbes 30 under 30 list in 2018 and in 2021 she became the first pharmacist to be recognized with the Academy Health Alice S. Hersh Emerging Leader Award. She is a Fellow of the American College of Cardiology and the American Heart Association.

connect with us


© UC Irvine School of Social Sciences - 3151 Social Sciences Plaza, Irvine, CA 92697-5100 - 949.824.2766